跳至主要内容
临床试验/NCT01140555
NCT01140555终止不适用

A Pilot Study to Determine the Optimal Procedure Steps to Obtain and Maintain Bilateral Uterine Artery Occlusion Using the GYNECARE GYNOCCLUDE™ Doppler Guided Uterine Artery Occlusion Device in Women With Uterine Fibroids

Ethicon, Inc.8 个研究点 分布在 4 个国家目标入组 2 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Ethicon, Inc.
入组人数
2
试验地点
8
主要终点
Optimal procedural steps

研究概览

简要总结

This pilot study has a sequential design involving three groups to ensure appropriate development and evaluation of the optimal procedural steps of the D-UAO device and to confirm that those steps are reproducible in the hands of multiple surgeons.

详细描述

  1. Group 1 - beginning with the use of the current instructions for use (IFU) will have adjustments made as necessary to the D-UAO procedural steps for uterine artery occlusion confirmed by 2/3-D Power Colour Doppler ultrasound (2/3DPD).
  2. Group 2 - verify that optimal D-UAO IFU procedural steps generated in Group 1 as confirmed by 2/3DPD.
  3. Group 3 - verify that the optimal D-UAO procedural steps are reproducible in the hands of multiple surgeons in addition to the group 1 investigators, as confirmed by 2/3DPD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 25-55 years with regular menses and at least one symptom related to uterine fibroids (for example heavy bleeding).
  • Completed child-bearing.
  • At least one uterine fibroid of 3 cm diameter or greater with a prevailing pathology (e.g. as opposed to adenomyosis) of fibroids determined through abdominal/transvaginal ultrasound.
  • Confirmation of the ability to clearly visualise bilateral uterine arteries with 2/3DPD.
  • Dominant fibroid (defined as >3cm in diameter) must be well vascularised as determined by CE-MRI (for Group 2 and 3 patients only).
  • Able to tolerate the required prolonged supine position during treatment (approximately 6 hours).
  • Cervix suitable for tenaculum placement as determined by pelvic exam.
  • Normal Pap smear within the last 36 months.
  • Agrees to participate in the study, and following review of the patient information sheet documents this agreement by signing the Ethics Committee approved informed consent.

排除标准

  • Prior endometrial ablation, uterine artery embolization, or uterine artery ligation.
  • Pregnancy (As confirmed by a urine pregnancy test at screening and immediately prior to procedure).
  • One or more lower uterine segment fibroids determined through pelvic exam which in the examiner's opinion would prevent proper clamp application.
  • Any known contraindications to the contrast agent to be used for the CE-MRI as determined by the study radiologist (for Group 2 and 3 patients only).
  • Pelvic mass outside the uterus suggesting other disease processes.
  • An intrauterine device (IUD) in place during the day of procedure.
  • Hydronephrosis as determined by interpretation of a pre-procedure renal ultrasound.
  • No ureteral jets observed on ultrasound prior to clamping.
  • Presence of a pedunculated fibroid determined by ultrasound, hysteroscopy, or saline infused sonography or CE MRI.
  • Any current acute or chronic systemic infection or localized pelvic infection, including an unresolved urinary tract infection.
  • Clinical history of any thromboembolic disease.
  • History of gynecologic malignancy, atypical endometrial hyperplasia, or pelvic inflammatory disease.
  • Using anticoagulation therapy (except OTC treatments, e.g. aspirin), or has a known underlying bleeding disorder.
  • In the investigator's opinion, any medical condition or psychiatric illness that could potentially be life threatening or affect their ability to complete the study visits according to this protocol.

结局指标

主要结局

Optimal procedural steps

时间窗: 6 hrs

Establish and verify optimal procedural steps to obtain and maintain bilateral uterine artery occlusion using the GYNECARE GYNOCCLUDE™ Doppler Guided Uterine Artery Occlusion Device (D-UAO) for 6 hours, and confirm that these optimal procedural steps are reproducible by multiple surgeons

次要结局

  • Fibroid devascularization(Baseline and 1 month post procedure)
  • Safety(Baseline through one month post procedure)

研究者

发起方
Ethicon, Inc.
申办方类型
Industry

研究点 (8)

Loading locations...

相似试验

A Pilot Study to Determine Optimal Procedure Steps... | 临床试验